Skip to content
  • Who We Are
    • About Us
      • Nobel Prize
      • ISB Today
      • What is Systems Biology?
      • Our History
      • Contact ISB
    • People
      • Leadership
      • Board of Directors
      • Director Emeritus
      • Faculty
      • Education Directors
      • Principal Scientists
      • Senior Research Scientists
      • Affiliate Faculty
      • Scientific Advisory Board
    • Labs
      • All Labs
    • Careers
      • Work At ISB
      • Faculty Development
      • Postdoctoral Fellowships
      • Grad Student Opportunities
      • Internships
  • What We Do
    • Research Areas
      • All Research Areas
      • Cancer
      • Health
      • Infectious Disease
      • Chronic Illness
      • Environment
    • Education and Training
      • Education Initiatives
      • Educator Resources
      • Student Programs
      • Courses and Symposia
    • Published Research
      • Publications
    • Open Source Software
      • Software and Downloads
    • Services
      • Olink® Services
      • Proteomics Services
  • News and Events
    • News
      • ISB News
    • Newsletter
      • Subscribe
    • Events
      • Upcoming Events
      • Events Archive
    • Media
      • Media Coverage
      • Press Releases
      • Media Inquiries
    • Social Media
      • LinkedIn
      • Bluesky
      • X
      • Instagram
      • Facebook
      • YouTube
  • Ways To Give
    • Ways To Give
      • How You Can Help
    • Giving Priority Areas
      • My Digital Gut
      • STEM Education
      • HPV+ Cancer
      • Postdoctoral Fellowship Fund
    • Team
      • Meet Us
    • Donate Now
      • Donate →
Donate
clear

Featured News

A photograph depicting a woman in a sparkling ballgown shaking hands with a man in a tuxedo on a stage with standing dignitaries behind them.

Posted: December 16, 2025

People Press Release Hood Lab
ISB’s Dr. Mary Brunkow Wins 2025 Nobel Prize in Physiology or Medicine

ISB’s Dr. Mary Brunkow Wins 2025 Nobel Prize in Physiology or Medicine

The prize recognizes foundational discoveries about regulatory T cells and the FOXP3 gene that redefined immune tolerance and opened avenues to treat autoimmune disease, enable transplantation, and advance immuno-oncology. ISB celebrates Dr. Brunkow’s leadership and collaborative science.

ISB’s Dr. Mary Brunkow Wins 2025 Nobel Prize in Physiology or Medicine
ISB’s Dr. Mary Brunkow Wins 2025 Nobel Prize in Physiology or Medicine
Illustration of Drs. Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi, recipients of the 2025 Nobel Prize in Physiology or Medicine.

Posted: October 23, 2025

Cancer People Press Release
The Science Behind the Nobel Prize

The Science Behind the Nobel Prize

The pioneering work of Mary Brunkow and Fred Ramsdell began with a mysterious mutant mouse known as “scurfy,” leading them to identify the FOXP3 gene and unlock how regulatory T cells prevent autoimmune disease — discoveries that now point to new treatments in cancer and autoimmunity.

The Science Behind the Nobel Prize
The Science Behind the Nobel Prize

More News

 

Posted: May 12, 2026

Cancer Infectious Disease Press Release
A New Window Into the Immune System: ISB Researchers Develop Powerful Platform to Decode CD4+ T Cells

A New Window Into the Immune System: ISB Researchers Develop Powerful Platform to Decode CD4+ T Cells

Researchers at the Institute for Systems Biology have developed a powerful new platform that can identify and deeply profile antigen-specific CD4+ T cells at unprecedented scale and resolution. Published in Nature Communications, the work could help accelerate vaccine design, improve immune monitoring, and advance next-generation cancer immunotherapies.

A New Window Into the Immune System: ISB Researchers Develop Powerful Platform to Decode CD4+ T Cells
A New Window Into the Immune System: ISB Researchers Develop Powerful Platform to Decode CD4+ T Cells
A side-by-side image depicting portraits of Dr. Nitiin Baliga and Evan Pepper.

Posted: May 7, 2026

Infectious Disease Press Release Baliga Lab
How Host Stress May Prime Tuberculosis to Rapidly Gain Drug Resistance

How Host Stress May Prime Tuberculosis to Rapidly Gain Drug Resistance

ISB researchers show that oxidative stress generated by the host immune system can prime tuberculosis bacteria to rapidly evolve antibiotic resistance, revealing how resistance may begin before treatment.

How Host Stress May Prime Tuberculosis to Rapidly Gain Drug Resistance
How Host Stress May Prime Tuberculosis to Rapidly Gain Drug Resistance
Abstract Illustration of a Stylized Protein

Posted: May 6, 2026

Press Release Moritz Lab Proteins and Disease
Scientists Uncover 1,700+ Protein-like Molecules in the ‘Dark Proteome’

Scientists Uncover 1,700+ Protein-like Molecules in the ‘Dark Proteome’

ISB researchers help reveal a previously hidden layer of the human proteome, identifying a new class of protein-like molecules known as “peptideins” with potential implications for cancer, immunotherapy, and human disease.

Scientists Uncover 1,700+ Protein-like Molecules in the ‘Dark Proteome’
Scientists Uncover 1,700+ Protein-like Molecules in the ‘Dark Proteome’
Screen grab from the video recording of ISB Assistant Professor Dr. Alice Kane delivering a Research Roundtable presentation on how the body ages.

Posted: April 23, 2026

Events Health Kane Lab
How the Body Ages: Exploring Frailty, Menopause, and the Biology of Healthspan

How the Body Ages: Exploring Frailty, Menopause, and the Biology of Healthspan

ISB’s Dr. Alice Kane explores the biology of aging, highlighting frailty as a key measure of healthspan, new biomarkers of aging, and insights into menopause and women’s health.

How the Body Ages: Exploring Frailty, Menopause, and the Biology of Healthspan
How the Body Ages: Exploring Frailty, Menopause, and the Biology of Healthspan
An editorial illustration based on a figure from Dr. Wei's paper illustrating two diagrammatic states of a cancer cell.

Posted: April 15, 2026

Cancer Press Release Heath Lab
The Drug That Stops Cancer Also Teaches It How to Escape

The Drug That Stops Cancer Also Teaches It How to Escape

ISB researchers reveal a darker side of targeted therapy: the same oncogene inhibition that shuts down cancer growth program can also ignite a stress-driven identity switch — revealing an early escape route that may shape the future of cancer treatment

The Drug That Stops Cancer Also Teaches It How to Escape
The Drug That Stops Cancer Also Teaches It How to Escape
Photo of ISB Associate Professor Wei Wei alongside a graphical abstract illustrating how combined small-cell lung cancer can arise from a single tumor and evolve into multiple cell types and tumor microenvironments.

Posted: April 10, 2026

Cancer Wei Lab Understanding Tumors
When Cancer Changes Identity

When Cancer Changes Identity

A new study co-led by ISB and published in the journal Cell Reports Medicine reveals how a rare lung cancer can shift between cell types, pass through hybrid states, and build distinct tumor “neighborhoods” that may help it evade detection and resist treatment.

When Cancer Changes Identity
When Cancer Changes Identity
View All News

  • Who We Are
    • Work At ISB
    • People
  • What We Do
    • Research
    • Publications
  • News and Events
    • Media Inquiries
    • News
  • Services
    • Olink Services
    • Proteomics Services
  • Other
    • Sponsored Projects Resources
    • COI
ISB logo (1-color)
Donate Contact Us

Subscribe to Molecular Me, where we share news of our transformational research, devoted scientists and educators, upcoming events, and more.

© 2026 Institute for Systems Biology (ISB). All Rights Reserved
  • Login
  • Intranet
  • Purchase Terms
  • Terms of Service
  • Privacy Policy
Web Design by T-F